<DOC>
	<DOCNO>NCT02753530</DOCNO>
	<brief_summary>Funding Source - FDA OOPD . The purpose study evaluate safety efficacy study drug , Arimoclomol IBM patient .</brief_summary>
	<brief_title>Study Arimoclomol Inclusion Body Myositis ( IBM )</brief_title>
	<detailed_description />
	<mesh_term>Myositis</mesh_term>
	<mesh_term>Myositis , Inclusion Body</mesh_term>
	<criteria>Meet European Neuromuscular Centre Inclusion Body Myositis research diagnostic criterion 2011 category IBM Demonstrate able arise chair without support another person device Able ambulate least 20 ft/6 meter without assistive device . Once arisen chair , participant may use walk device , i.e . walker/frame , , crutch , brace . They support another person use furniture wall support . Body weight &gt; = 40 kg Premenopausal woman must negative pregnancy tst prior dose iwht study medication . If participant bimagrumab study , participant must study medication least 6 month . Able give inform consent History follow excludes subject participation study : chronic infection particularly HIV Hepatitis B C ; cancer basal cell cancer less five year prior ; chronic serious medical illness . Presence follow routine blood screening : WEB &lt; 3000 ; platelet &lt; 100,000 ; hematocrit , 30 % ; BUN &gt; 30 mg % ; creatinine &gt; 1.5 mg % ; symptomatic liver disease serum albumin &lt; 3 g/dL . History recent cratine kinase &gt; 15x upper limit normal without explanation besides IBM . History noncompliance therapy Use testosterone except physiologic replacement dose case androgen deficiency . Participants must document proof androgen deficiency . Coexistence disease would likely affect outcome measure . Drug alcohol abuse within past three month Participation recent drug study last 30 day prior screen visit use biologic agent le 6 month prior screen visit . Women lactate unwilling use adequate method birth control surgically sterile . Adequate birth control include use intrauterine device , abstinence , oral contraceptive double barrier method , e.g condom plas diaphragm necessary male female participant .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>